Last Updated: 06/01/2025

Active surveillance for P. falciparum drug resistance with assessment of transmission blocking activity of single dose primaquine in Cambodia

Objectives

1. To monitor therapeutic efficacy of DHA-piperaquine for P.f.  

2. To assess transmission blocking activity of single low-dose primaquine.

 

Principal Institution

Armed Forces Research Institute of Medical Sciences (AFRIMS), United States

Principal Investigators / Focal Persons

David Saunders

Partner Institutions

National Center for Parasitology, Entomology and Malaria Control (CNM) Cambodia, Cambodia
Royal Cambodian Armed Forces (RCAF), Cambodia

Themes

Drug Resistance
Drug-based Strategies

Date

Dec 2012 — Dec 2014

Project Site

Asia, Southeastern
Cambodia

SHARE

Related Resources

Malaria Molecular Surveillance Study Design workshop
Training
MESA FORUM: Updates on the WHO guidance for pfhrp2/3 gene deletions surveillance and recently completed surveys
Multimedia
From Data to Insight – A Practical Introduction to Interpreting Malaria Genetics for Surveillance
Training

Related Projects

Nov 2023 —
Oct 2027
Dissecting the potential of Pseudomonas as a new malaria transmission blocking tool
NOVA University Lisbon (UNL), Portugal
Jan 2022 —
Dec 2022

$130,000

Screening for transmission blocking drugs
London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom
Apr 2024 —
Oct 2030
Age de-escalation trial of transmission blocking vaccine candidate Pfs230D1-EPA/AS01 to assess safety and tolerability in children and community trial to assess efficacy in family compounds
National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), United States; University of Sciences Techniques and Technologies of Bamako (USTTB), Mali
SHARE